Enstilar and Hyperlipidaemia - a phase IV clinical study of FDA data

Summary:

Hyperlipidaemia is reported as a side effect among people who take Enstilar (betamethasone dipropionate; calcipotriene), especially for people who are male, 60+ old, also take Humira, and have Psoriasis.

The phase IV clinical study analyzes which people have Hyperlipidaemia when taking Enstilar. It is created by eHealthMe based on reports of 1,668 people who have side effects when taking Enstilar from the FDA, and is updated regularly.

What is Enstilar?

Enstilar has active ingredients of betamethasone dipropionate; calcipotriene. eHealthMe is studying from 1,673 Enstilar users. Check the latest studies of Enstilar.

What is Hyperlipidaemia?

Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,422 drugs and 1,410 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

1,668 people reported to have side effects when taking Enstilar.
Among them, 11 people (0.66%) have Hyperlipidaemia.

Among these 11 people:

What is the gender of people who have Hyperlipidaemia when taking Enstilar? *

female: 0.0 %
male: 100 %

What is the age of people who have Hyperlipidaemia when taking Enstilar? *

What are other drugs people take besides Enstilar? *

Pantoprazole: 8 people, 72.73%
Humira: 8 people, 72.73%
Eliquis: 6 people, 54.55%
Cosentyx: 2 people, 18.18%
Apixaban: 2 people, 18.18%

What are other side effects people have besides Hyperlipidaemia? *

Abdominal Pain: 8 people, 72.73%
Myocardial Fibrosis (a condition in which the heart's muscle cells are impaired): 8 people, 72.73%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 8 people, 72.73%
Dizziness: 8 people, 72.73%
Flatulence (flatus expelled through the anus): 8 people, 72.73%
High Blood Cholesterol: 8 people, 72.73%
Cardiac Failure: 8 people, 72.73%
Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back)): 8 people, 72.73%
Osgood-Schlatter Disease (an overuse injury that occurs in the knee area of growing adolescents. it is caused by inflammation of the tendon below the kneecap): 8 people, 72.73%
Splenomegaly (enlargement of spleen): 8 people, 72.73%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 10 people, 90.91%
High Blood Pressure: 8 people, 72.73%
High Blood Cholesterol: 8 people, 72.73%
Cardiac Failure: 8 people, 72.73%
Arrhythmias (irregular heartbeat): 8 people, 72.73%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 54.55%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 18.18%
Allergy To Animal: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Enstilar and have Hyperlipidaemia?

- Check whether Hyperlipidaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enstilar:

Enstilar (1,673 reports)

Hyperlipidaemia treatments and more:

Hyperlipidaemia (86,394 reports)

How severe was Hyperlipidaemia and when was it recovered:

Hyperlipidaemia in Enstilar

Expand to all the drugs that have ingredients of betamethasone dipropionate; calcipotriene:

Hyperlipidaemia and drugs with ingredients of betamethasone dipropionate; calcipotriene

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Enstilar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperlipidaemia:

Hyperlipidaemia (1,422 drugs)

Browse all the conditions that are associated with Hyperlipidaemia:

Hyperlipidaemia (1,410 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone dipropionate; calcipotriene (the active ingredients of Enstilar) and Enstilar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.